These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22041327)

  • 1. Low systolic blood pressure at admission predicts long-term mortality in heart failure with preserved ejection fraction.
    Buiciuc O; Rusinaru D; Lévy F; Peltier M; Slama M; Leborgne L; Tribouilloy C
    J Card Fail; 2011 Nov; 17(11):907-15. PubMed ID: 22041327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial.
    Ambrosy AP; Vaduganathan M; Mentz RJ; Greene SJ; Subačius H; Konstam MA; Maggioni AP; Swedberg K; Gheorghiade M
    Am Heart J; 2013 Feb; 165(2):216-25. PubMed ID: 23351825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of blood pressure at hospital discharge with mortality in patients diagnosed with heart failure.
    Lee DS; Ghosh N; Floras JS; Newton GE; Austin PC; Wang X; Liu PP; Stukel TA; Tu JV
    Circ Heart Fail; 2009 Nov; 2(6):616-23. PubMed ID: 19919987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated admission systolic blood pressure after blunt trauma predicts delayed pneumonia and mortality.
    Ley EJ; Singer MB; Clond MA; Gangi A; Mirocha J; Bukur M; Brown CV; Salim A
    J Trauma; 2011 Dec; 71(6):1689-93. PubMed ID: 22182876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure.
    Gheorghiade M; Abraham WT; Albert NM; Greenberg BH; O'Connor CM; She L; Stough WG; Yancy CW; Young JB; Fonarow GC;
    JAMA; 2006 Nov; 296(18):2217-26. PubMed ID: 17090768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between admission systolic blood pressure of heart failure patients with preserved systolic function and mortality outcomes.
    Rosman Y; Kopel E; Shlomai G; Goldenberg I; Grossman E
    Eur J Intern Med; 2015 Dec; 26(10):807-12. PubMed ID: 26525208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of Low Systolic Blood Pressure at Discharge in Patients with Heart Failure and Preserved Ejection Fraction.
    Li S; Li X
    High Blood Press Cardiovasc Prev; 2017 Dec; 24(4):405-412. PubMed ID: 28725953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between blood pressure and mortality in patients with heart failure.
    Lee TT; Chen J; Cohen DJ; Tsao L
    Am Heart J; 2006 Jan; 151(1):76-83. PubMed ID: 16368295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program.
    Meredith PA; Ostergren J; Anand I; Puu M; Solomon SD; Michelson EL; Olofsson B; Granger CB; Yusuf S; Swedberg K; Pfeffer MA; McMurray JJ
    J Am Coll Cardiol; 2008 Dec; 52(24):2000-7. PubMed ID: 19055992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
    J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of baseline and changes in systolic blood pressure over time on the effectiveness of valsartan in the Valsartan Heart Failure Trial.
    Anand IS; Rector TS; Kuskowski M; Thomas S; Holwerda NJ; Cohn JN
    Circ Heart Fail; 2008 May; 1(1):34-42. PubMed ID: 19808268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors.
    Güder G; Frantz S; Bauersachs J; Allolio B; Wanner C; Koller MT; Ertl G; Angermann CE; Störk S
    Circ Heart Fail; 2009 Nov; 2(6):563-71. PubMed ID: 19919981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin levels predict survival in patients with heart failure and preserved ejection fraction.
    Liu M; Chan CP; Yan BP; Zhang Q; Lam YY; Li RJ; Sanderson JE; Coats AJ; Sun JP; Yip GW; Yu CM
    Eur J Heart Fail; 2012 Jan; 14(1):39-44. PubMed ID: 22158777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential prognostic effect of systolic blood pressure on mortality according to left-ventricular function in patients with acute heart failure.
    Núñez J; Núñez E; Fonarow GC; Sanchis J; Bodí V; Bertomeu-González V; Miñana G; Merlos P; Bertomeu-Martínez V; Redón J; Chorro FJ; Llàcer A
    Eur J Heart Fail; 2010 Jan; 12(1):38-44. PubMed ID: 20023043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of bundle branch block to long-term (four-year) mortality in hospitalized patients with systolic heart failure.
    Barsheshet A; Goldenberg I; Garty M; Gottlieb S; Sandach A; Laish-Farkash A; Eldar M; Glikson M
    Am J Cardiol; 2011 Feb; 107(4):540-4. PubMed ID: 21184999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.
    Yancy CW; Lopatin M; Stevenson LW; De Marco T; Fonarow GC;
    J Am Coll Cardiol; 2006 Jan; 47(1):76-84. PubMed ID: 16386668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
    Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR;
    Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction.
    Pérez de Isla L; Zamorano J; Hernández N; Contreras L; Rodrigo JL; Almería C; Aubele AL; Mataix L; Macaya C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1011-5. PubMed ID: 18799963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The determination of the factors impacting on in-hospital mortality in patients with acute heart failure in a tertiary referral center].
    Zoghi M; Duygu H; Güngör H; Nalbantgil S; Yilmaz GM; Tülüce K; Ozerkan F; Akilli A; Akin M
    Anadolu Kardiyol Derg; 2008 Aug; 8(4):255-9. PubMed ID: 18676300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemia in patients with heart failure and preserved systolic function.
    Felker GM; Shaw LK; Stough WG; O'Connor CM
    Am Heart J; 2006 Feb; 151(2):457-62. PubMed ID: 16442914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.